Dow (DOW) drew fresh interest after Univar Solutions expanded its agreement to distribute the SupraCare line of polymers and specialty additives across the United States and Canada, widening access to Dow’s homecare and industrial cleaning ingredients.
Recent trading has been choppy for Dow, with the share price down 7.62% over the past 30 days and 3.51% over 90 days, even as the year to date share price return is 15.45% and the 1 year total shareholder return is 28.06%. In contrast, the 3 and 5 year total shareholder returns show sizeable declines, which suggests that shorter term momentum contrasts with a weaker longer term record as investors reassess both growth potential and risk around moves like the SupraCare distribution expansion.
Scan beyond Dow and see how other material and specialty chemical players with fresh catalysts stack up using our curated list of list of solid balance sheet and fundamentals (24 results)
Short term gains and a new SupraCare push sit against multiyear share price declines and a recent loss. Does that mix still leave Dow’s current valuation tilted toward buyers on a risk reward basis?
Against a last close of $28.02, the most followed narrative for Dow anchors on a fair value of $34.69, which frames the SupraCare news within a wider focus on cash flow, cost control and asset reshaping.
Dow is targeting at least $1 billion in annual cost reductions by 2026, focusing on areas such as purchased services and contract labor. These cost-cutting measures aim to improve net margins and bolster earnings despite a challenging macroeconomic environment.
See why 89 investors see Dow as 19% undervalued.
Result: Fair Value of $34.69 (UNDERVALUED)
Still, the narrative around Dow could unravel if energy and feedstock costs stay elevated or if prolonged weak demand in Europe keeps pressure on profitability.
Find out about the key risks to this Dow narrative.
Mixed signals around Dow can be confusing, so move quickly to review both sides of the story and weigh the 4 key rewards and 2 important warning signs
If Dow has your attention but you want a broader watchlist, now is the moment to line up a few more high conviction candidates before markets move.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com